Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

References for PMC Articles for PubMed (Select 18511696)

1.

Heritability of platelet function in families with premature coronary artery disease.

Bray PF, Mathias RA, Faraday N, Yanek LR, Fallin MD, Herrera-Galeano JE, Wilson AF, Becker LC, Becker DM.

J Thromb Haemost. 2007 Aug;5(8):1617-23.

PMID:
17663734
2.

Aspirin resistance and adverse clinical events in patients with coronary artery disease.

Chen WH, Cheng X, Lee PY, Ng W, Kwok JY, Tse HF, Lau CP.

Am J Med. 2007 Jul;120(7):631-5.

PMID:
17602938
3.

Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1.

Faraday N, Yanek LR, Mathias R, Herrera-Galeano JE, Vaidya D, Moy TF, Fallin MD, Wilson AF, Bray PF, Becker LC, Becker DM.

Circulation. 2007 May 15;115(19):2490-6. Epub 2007 Apr 30.

4.

Platelet hyperreactivity generalizes to multiple forms of stimulation.

Yee DL, Bergeron AL, Sun CW, Dong JF, Bray PF.

J Thromb Haemost. 2006 Sep;4(9):2043-50.

PMID:
16961612
5.

Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.

Faraday N, Becker DM, Yanek LR, Herrera-Galeano JE, Segal JB, Moy TF, Bray PF, Becker LC.

Am J Cardiol. 2006 Sep 15;98(6):774-9. Epub 2006 Jul 28.

PMID:
16950183
6.

The aspirin resistance controversy: clinical entity or platelet heterogeneity?

Freedman JE.

Circulation. 2006 Jun 27;113(25):2865-7. No abstract available.

7.

Sex differences in platelet reactivity and response to low-dose aspirin therapy.

Becker DM, Segal J, Vaidya D, Yanek LR, Herrera-Galeano JE, Bray PF, Moy TF, Becker LC, Faraday N.

JAMA. 2006 Mar 22;295(12):1420-7.

PMID:
16551714
8.

Novel targets for antithrombotic drug discovery.

Nanda N, Phillips DR.

Blood Cells Mol Dis. 2006 Mar-Apr;36(2):228-31. Epub 2006 Feb 13. Review.

PMID:
16473533
9.

Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.

Cooke GE, Liu-Stratton Y, Ferketich AK, Moeschberger ML, Frid DJ, Magorien RD, Bray PF, Binkley PF, Goldschmidt-Clermont PJ.

J Am Coll Cardiol. 2006 Feb 7;47(3):541-6. Epub 2006 Jan 18.

10.

A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction.

Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U, Gudbjartsson DF, Gretarsdottir S, Magnusson KP, Gudmundsson G, Hicks A, Jonsson T, Grant SF, Sainz J, O'Brien SJ, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Levey AI, Abramson JL, Reilly MP, Vaccarino V, Wolfe ML, Gudnason V, Quyyumi AA, Topol EJ, Rader DJ, Thorgeirsson G, Gulcher JR, Hakonarson H, Kong A, Stefansson K.

Nat Genet. 2006 Jan;38(1):68-74. Epub 2005 Nov 10.

PMID:
16282974
11.

Aspirin resistance and atherothrombotic disease.

Mason PJ, Jacobs AK, Freedman JE.

J Am Coll Cardiol. 2005 Sep 20;46(6):986-93. Review.

12.

Ligand-specific glucocorticoid receptor activation in human platelets.

Moraes LA, Paul-Clark MJ, Rickman A, Flower RJ, Goulding NJ, Perretti M.

Blood. 2005 Dec 15;106(13):4167-75. Epub 2005 Aug 30.

13.

Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation.

Nanda N, Bao M, Lin H, Clauser K, Komuves L, Quertermous T, Conley PB, Phillips DR, Hart MJ.

J Biol Chem. 2005 Jul 1;280(26):24680-9. Epub 2005 Apr 25.

14.

SNP cherry picker: maximizing the chance of finding an association with a disease SNP.

Harris M, Martin JM, Peden JF, Rawlings CJ.

Bioinformatics. 2003 Nov 1;19(16):2141-3.

15.

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease.

Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ.

J Am Coll Cardiol. 2003 Mar 19;41(6):961-5. Erratum in: J Am Coll Cardiol. 2006 Nov 7;48(9):1918.

PMID:
12651041
16.

Genetic variation in cyclooxygenase 1: effects on response to aspirin.

Halushka MK, Walker LP, Halushka PV.

Clin Pharmacol Ther. 2003 Jan;73(1):122-30.

PMID:
12545150
17.

Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred.

Prevost N, Woulfe D, Tanaka T, Brass LF.

Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9219-24. Epub 2002 Jun 25.

18.
19.

Profile and prevalence of aspirin resistance in patients with cardiovascular disease.

Gum PA, Kottke-Marchant K, Poggio ED, Gurm H, Welsh PA, Brooks L, Sapp SK, Topol EJ.

Am J Cardiol. 2001 Aug 1;88(3):230-5.

PMID:
11472699
20.

Genetic and environmental contributions to platelet aggregation: the Framingham heart study.

O'Donnell CJ, Larson MG, Feng D, Sutherland PA, Lindpaintner K, Myers RH, D'Agostino RA, Levy D, Tofler GH; Framingham Heart Study.

Circulation. 2001 Jun 26;103(25):3051-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk